SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 117 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $170,000 | +1.8% | 15,175 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $167,000 | +1.8% | 15,175 | -9.5% | 0.00% | 0.0% |
| Q1 2017 | $164,000 | 0.0% | 16,775 | +10.6% | 0.00% | 0.0% |
| Q4 2016 | $164,000 | +5.8% | 15,168 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $155,000 | +33.6% | 15,168 | +43.8% | 0.00% | 0.0% |
| Q1 2016 | $116,000 | +7.4% | 10,548 | -10.4% | 0.00% | 0.0% |
| Q4 2015 | $108,000 | +31.7% | 11,773 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $82,000 | -29.3% | 11,773 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $116,000 | +11.5% | 11,773 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $104,000 | +1.0% | 11,773 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $103,000 | +33.8% | 11,773 | +5.6% | 0.00% | 0.0% |
| Q3 2014 | $77,000 | +20.3% | 11,148 | -7.8% | 0.00% | 0.0% |
| Q2 2014 | $64,000 | -61.2% | 12,088 | -66.7% | 0.00% | -50.0% |
| Q1 2014 | $165,000 | -10.3% | 36,303 | -0.4% | 0.00% | 0.0% |
| Q4 2013 | $184,000 | -6.1% | 36,463 | -5.5% | 0.00% | 0.0% |
| Q3 2013 | $196,000 | – | 38,573 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athos Capital Ltd | 410,389 | $4,596,000 | 3.46% |
| GLG Partners LP | 2,586,437 | $28,968,000 | 1.54% |
| Nine Chapters Capital Management LLC | 32,300 | $362,000 | 0.80% |
| FNY Partners Fund LP | 335,900 | $3,762,000 | 0.64% |
| MENTA CAPITAL LLC | 373,523 | $4,183,000 | 0.61% |
| Yakira Capital Management, Inc. | 85,500 | $958,000 | 0.32% |
| Sapphire Star Partners LP | 18,724 | $209,000 | 0.27% |
| GAM Holding AG | 541,025 | $6,059,000 | 0.26% |
| Bowling Portfolio Management LLC | 127,873 | $1,432,000 | 0.22% |
| Kassirer Asset Management Corp | 15,000 | $168,000 | 0.16% |